Workflow
秋乐种业(831087) - 2024 Q3 - 季度财报
831087DQiule Seeds(831087)2024-10-28 10:44

Financial Performance - Operating revenue for the first nine months of 2024 decreased by 28.63% to CNY 163,495,540.75, down from CNY 229,089,960.59 in the same period of 2023[4] - Net profit attributable to shareholders decreased by 48.88% to CNY 9,215,462.95 for the first nine months of 2024, compared to CNY 18,028,069.18 in 2023[4] - The company's weighted average return on equity based on net profit attributable to shareholders was 1.73%, down from 3.70% in the previous year[4] - The company's operating revenue for the first nine months of 2024 was ¥104,196,102.61, a decrease of 34.3% compared to ¥158,561,674.50 in the same period of 2023[24] - Operating profit for the first nine months of 2024 was -¥4,727,022.63, compared to a profit of ¥9,191,713.36 in the same period of 2023, indicating a significant decline[24] - The net profit for the first nine months of 2024 was -¥4,677,028.42, a stark contrast to the net profit of ¥11,220,998.94 in the same period of 2023[24] - The company's total profit for the first nine months of 2024 was -¥4,677,028.42, compared to ¥11,220,998.94 in 2023, indicating a significant downturn in profitability[24] Cash Flow - The company reported a net cash flow from operating activities of CNY -36,732,633.07 for the third quarter of 2024, a decline of 188.80% compared to CNY 41,366,288.63 in the same period of 2023[4] - Cash flow from operating activities decreased by 56.92% to ¥21,861,059.93, primarily due to reduced cash received from sales of goods and services[6] - Operating cash inflow for the first nine months of 2024 was CNY 304,233,973.83, a decrease of 22.8% compared to CNY 394,215,133.55 in the same period of 2023[26] - Net cash flow from operating activities for the first nine months of 2024 was CNY 21,861,059.93, down 56.9% from CNY 50,739,456.62 in the previous year[26] - Cash inflow from sales of goods and services for the first nine months of 2024 was CNY 285,967,555.25, down 25.5% from CNY 383,402,255.03 in 2023[26] - The ending cash and cash equivalents balance for the first nine months of 2024 was CNY 270,962,199.95, down from CNY 301,323,826.00 in 2023, a decrease of 10.1%[27] Assets and Liabilities - Total assets increased by 16.15% to CNY 887,787,063.47 as of September 30, 2024, compared to CNY 764,348,367.35 at the end of 2023[4] - Total liabilities reached ¥368,103,179.99, compared to ¥220,839,946.82, reflecting an increase of approximately 66.7%[17] - The company's equity decreased to ¥519,683,883.48 from ¥543,508,420.53, a decline of about 4.4%[17] - Total assets reached CNY 874,064,698.42, an increase of 15.9% compared to CNY 754,540,345.76[20] - Total liabilities increased to CNY 358,240,867.61, up 78.2% from CNY 200,999,486.53[19] Research and Development - Research and development expenses increased by 47.18% to CNY 10,037,379.72, reflecting the company's commitment to enhancing research capabilities[5] - Research and development expenses increased to ¥9,563,330.79 in 2024 from ¥6,254,670.33 in 2023, reflecting a growth of 53.7%[24] Investments - The company’s financial assets increased by 160.11% to CNY 130,054,000.00 due to the purchase of financial products during the reporting period[5] - Investment income increased to ¥2,215,752.28, a rise of 143.61% due to increased financial management income[6] - Cash inflow from investment activities increased significantly to CNY 730,550,933.47 in 2024, compared to CNY 311,024,114.30 in 2023, marking a growth of 134.0%[26] - Cash inflow from the recovery of investments was CNY 719,213,000.00 in 2024, significantly higher than CNY 310,000,000.00 in 2023, reflecting a growth of 132.5%[28] Shareholder Information - The total number of unrestricted shares increased to 160,561,325, representing 97.19% of total shares[8] - The company distributed dividends amounting to ¥33,040,000.00, an increase of 33.33% compared to the previous period[6] - The company has no pledged or judicially frozen shares among its top ten shareholders[11]